---
title: Acromion Gmbh vs Genelife Clinical Research Pvt. Ltd.
slug_a: acromion-gmbh
slug_b: genelifecr
site: cro
review_signal_gate: closed
canonical_path: /compare/acromion-gmbh/genelifecr
---

# Acromion Gmbh vs Genelife Clinical Research Pvt. Ltd.

Side-by-side profile data from each company listing on this directory.

## Acromion Gmbh

- Profile: [/companies/acromion-gmbh](/companies/acromion-gmbh)

Acromion Gmbh — European full-service CRO supporting clinical development from Phase I to IV and non-interventional studies, with expertise in clinical monitoring, data management, biostatistics, medical writing, and regulatory affairs.

Services: 12. Modalities: 0. Indications: 0. Locations: 1. Certifications: 0. The strongest documented coverage currently appears in services (12).

### Services

- Clinical Trial Services
- Phase I Clinical Trials
- Phase II Clinical Trials
- Phase III Clinical Trials
- Phase IV / Post-Marketing
- Clinical Operations
- Data Management & eClinical
- Biostatistics & Statistical Programming
- Pharmacovigilance & Drug Safety
- Medical Writing
- Regulatory Affairs
- EU EMA Regulatory Strategy

### Modalities

- Data not yet provided.

### Indications

- Data not yet provided.

### Phases

- Phase I
- Phase II
- Phase III
- Phase IV

### Sourcing models

- Full-Service Outsourcing (FSO)

## Genelife Clinical Research Pvt. Ltd.

- Profile: [/companies/genelifecr](/companies/genelifecr)

Genelife Clinical Research Pvt. Ltd. — CDSCO-registered CRO in India running Phase I–IV trials, real world evidence studies, and bioequivalence (BABE) studies for pharma, biotech, and device sponsors. Offices in Mumbai, California, Cambridge, and Hamburg support multi-regional programs.

Services: 13. Modalities: 4. Indications: 4. Locations: 4. Certifications: 1. The strongest documented coverage currently appears in services (13).

### Services

- Phase I Clinical Trials
- Phase II Clinical Trials
- Phase III Clinical Trials
- Phase IV / Post-Marketing
- Clinical Operations
- Data Management & eClinical
- Biostatistics & Statistical Programming
- Pharmacovigilance & Drug Safety
- Medical Writing
- Central Laboratory Services
- Regulatory Affairs
- US FDA Regulatory Strategy
- EU EMA Regulatory Strategy

### Modalities

- Small Molecule
- Biologics (Other)
- Peptide
- Vaccine

### Indications

- Oncology
- Neurology
- Cardiovascular
- Dermatology

### Phases

- Phase I
- Phase II
- Phase III
- Phase IV
- Real-World Evidence (RWE) / Registries

### Sourcing models

- Full-Service Outsourcing (FSO)